We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.91B
AUM Growth
+$22.1M
Cap. Flow
-$74.9M
Cap. Flow %
-2.58%
Top 10 Hldgs %
28.1%
Holding
260
New
19
Increased
62
Reduced
99
Closed
10

Sector Composition

1 Technology 18.24%
2 Healthcare 18.14%
3 Industrials 15.39%
4 Financials 12.06%
5 Consumer Discretionary 11.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
126
Dover
DOV
$29.3B
$2.52M 0.09%
30,903
-124
-0.4% -$9.6K
GLOP
127
DELISTED
GASLOG PARTNERS LP
GLOP
$2.46M 0.08%
99,225
-174,625
-64% -$4.05M
POPE
128
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$2.21M 0.08%
+31,763
New +$2.25M
WPC icon
129
W.P. Carey
WPC
$16.7B
$2.21M 0.08%
32,672
NTRS icon
130
Northern Trust
NTRS
$34.9B
$2.06M 0.07%
20,660
UHT
131
Universal Health Realty Income Trust
UHT
$608M
$2.06M 0.07%
27,483
CDK
132
DELISTED
CDK Global, Inc.
CDK
$2.05M 0.07%
28,734
SPGI icon
133
S&P Global
SPGI
$135B
$1.96M 0.07%
11,560
XPO icon
134
XPO
XPO
$25.7B
$1.95M 0.07%
61,529
-6,202
-9% -$159K
SWN
135
DELISTED
Southwestern Energy Company
SWN
$1.92M 0.07%
344,850
-5,300
-2% -$30.8K
AMZN icon
136
Amazon
AMZN
$2.69T
$1.92M 0.07%
32,800
-300
-0.9% -$16.5K
EMR icon
137
Emerson Electric
EMR
$77.9B
$1.91M 0.07%
27,358
NVS icon
138
Novartis
NVS
$291B
$1.85M 0.06%
24,660
MTDR icon
139
Matador Resources
MTDR
$6.59B
$1.84M 0.06%
59,225
-7,350
-11% -$202K
DHI icon
140
D.R. Horton
DHI
$43.8B
$1.79M 0.06%
35,125
-31,350
-47% -$1.46M
ECL icon
141
Ecolab
ECL
$77.6B
$1.77M 0.06%
13,165
+70
+0.5% +$9.31K
BDX icon
142
Becton Dickinson
BDX
$44.1B
$1.75M 0.06%
8,379
OVV icon
143
Ovintiv
OVV
$15.9B
$1.67M 0.06%
25,121
-387
-2% -$22.8K
NTRP
144
DELISTED
Neurotrope, Inc. Common
NTRP
$1.67M 0.06%
237,193
+86,400
+57% +$503K
SJR
145
DELISTED
Shaw Communications Inc.
SJR
$1.65M 0.06%
72,142
-5,100
-7% -$115K
BMY icon
146
Bristol-Myers Squibb
BMY
$124B
$1.6M 0.06%
26,119
-100
-0.4% -$6.25K
TPL icon
147
Texas Pacific Land
TPL
$28.7B
$1.56M 0.05%
+31,500
New +$1.43M
AMGN icon
148
Amgen
AMGN
$201B
$1.51M 0.05%
8,685
+150
+2% +$26.5K
FCNCA icon
149
First Citizens BancShares
FCNCA
$25B
$1.49M 0.05%
3,695
T icon
150
AT&T
T
$153B
$1.46M 0.05%
49,647
-1,650
-3% -$45.1K

Similar funds

Cannell & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Cannell & Co held 260 positions worth $2.91B, up 0.77% from $2.88B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2017 filing shows 19 new, 62 increased, 99 reduced and 10 closed positions. Its largest new stake was Qualcomm: 971,690 shares worth $62.2M. The largest sale was Fidelity National Financial, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Co's largest Q4 2017 buy was Qualcomm: 971,690 shares worth $62.2M.
  • Cannell & Co added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $36M increase.
  • Cannell & Co's biggest Q4 2017 reduction was Fidelity National Financial, cutting an estimated $77.7M.
  • Cannell & Co fully exited Bausch Health in Q4 2017, selling an estimated $21.5M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.91B portfolio in Q4 2017.
  • Cannell & Co opened 19 new positions and closed 10 in Q4 2017.
  • Cannell & Co's portfolio value rose 0.77% quarter-over-quarter to $2.91B.

Based on Cannell & Co's 13F filing for Q4 2017, filed 13 Feb 2018.